News

FDA approves drug for treating postpartum depression

FDA approves drug for treating postpartum depression
Health
TRENTON, N.J. -- The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth.

The agency on Tuesday approved Sage Therapeutics Zulresso (ZUHL -ress-oh), an IV drug given over 2 1/2 days.

In a company-funded study of new mothers with moderate or severe postpartum depression, half the women given Zulresso had depression end within 2 1/2 days, about double the rate of those in a comparison group given dummy treatments.

Postpartum depression affects about 400,000 American women a year. It s often treated with antidepressants, though they can take several weeks to help and don t always work.
Read more on CTVnews
News Topics :
Similar Articles :
Health
The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth. The agency on Tuesday approved Sage Therapeutics’ Zulresso, an IV drug given...
Top Stories
U.S. regulators have approved the first drug specifically developed to treat postpartum depression in women, but some experts are raising questions about the treatments safety. The U.S. Food and Drug...
Business
NEW YORK A drug to treat severe postpartum depression showed positive results in a mid stage study, sending shares developer Sage Therapeutics skyrocketing Tuesday. There are no approved drugs that...
Health
According to the study , which was published in the journal Proceedings of the National Academy of Sciences, tryptophan, tyrosine and blueberry extract with blueberry juice for anti oxidant effects can...
Science
Postpartum depression a household term since actress Brooke Shields went public in 2005 about her struggle with it is indeed serious. But depression that begins before or during pregnancy is often more...